Howard v. United Serum Co.

211 N.W. 419, 202 Iowa 822
CourtSupreme Court of Iowa
DecidedDecember 14, 1926
StatusPublished
Cited by4 cases

This text of 211 N.W. 419 (Howard v. United Serum Co.) is published on Counsel Stack Legal Research, covering Supreme Court of Iowa primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Howard v. United Serum Co., 211 N.W. 419, 202 Iowa 822 (iowa 1926).

Opinion

Evans, J.

The Waterloo Serum Laboratories, Inc., was a corporation organized by Dr. Cecil; as its sole incorporator and *823 stockholder and manager. It is represented here by a receiver, but, for the purpose of our discussion, we shall refer to the corporation itself as the plaintiff. The plaintiff handled hog cholera serum and virus, as a retail dealer, and was located at Waterloo. In January, 1920, it entered into a written contract of purchase of this hog cholera remedy from the defendant. The contention presented is that the product delivered to it by the defendant was impure, in that it contained the germs of hemorrhagic septicemia and necrotic enteritis; that such diseases were communicated by its use in vaccination to the vaccinated pigs; and that there was large mortality among such vaccinated pigs, resulting from such diseases. The further contention is that such results so operated upon the reputation of plaintiff’s business that such business was virtually destroyed. Damages are claimed to the amount of $40,000. Plaintiff pleaded that, in January, 1920, it entered into a written contract for such products with the defendant. The portion of such contract which is material for our consideration' was as follows:

■ “It is further agreed and understood by the parties hereto that the United Serum Company does not guarantee the serum and virus mentioned in this contract further than that it will be made and manufactured strictly in’ accordance with the rules and regulations as laid down by the department of agriculture and that they will not be responsible for any representation or guaranty made by the party of the second part further than above mentioned. - It is further understood and agreed that the serum and virus herein referred to is to be manufactured or produced under the present rules, regulations and inspection of the department of agriculture and under the license issued to' the Stockyards Serum Company, and any revocation of said license shall render this contract null and void.”

The petition set forth six alleged grounds of negligence in the method of production of the product delivered pursuant to the foregoing contract. Specifications 4- and 6 were withdrawn from the jury by the court. Those submitted were Nos. 1, 2, 3, and 5, as follows:

“1. That-the defendant, while .said alleged remedies were in the process of preparation, kept their animals in inclosurés which *824 were not properly disinfected or rendered clean and free from disease germs, sncli as are discovered in Count 1 hereof.”

‘ ‘ 2. That said pens or inclosures in which the animals were kept, and whose blood was used in the manufacture or preparation of the alleged remedies, were in fact infected with the disease germs and deleterious substances described in Count 1 hereof, and to the knowledge of this defendant, or that knowledge by the defendant could and would have been obtained by the use of ordinary and reasonable care.”

“3. The pigs from which the blood was drawn to be used in the manufacture of said serum and virus, were not ‘susceptible’ pigs and were' not healthy animals, but were, or some of them were, suffering from the diseases or sickness referred to in Count 1 of this petition; that as a result the serum and virus were likewise infected or infested therewith, resulting in the communication of said diseases to the hog subsequently treated by the use of said alleged remedies.”

“5. The defendant failed and neglected to maintain at its plant for the manufacture of said remedies any laboratory or laboratory facilities for the purpose of testing the product, either during its manufacture or afterwards, for the purpose of ascertaining either its potency or its freedom from injurious substances and disease germs. ’ ’

The defendant demurred to the petition on the ground that no specification of negligence therein was predicated upon any breach of the government regulations for the production of such remedy. This demurrer was overruled. The defendant saved an exception to the ruling, and presents the same in one of its assignments of error. The question presented was saved throughout the trial by proper objections to evidence and by proper requests for instructions. We find no evidence in the record that would justify the submission of Specifications 1, 2, and 3. The purported support of such specifications is purely argumentative. The fifth specification of negligence is not only supported by the evidence, but is conceded by the defendant. The controlling question at this point is whether the fact set forth in such specification constituted negligence, either as a matter of law or fact. It will be noted that the damages claimed by the plaintiff are apparently remote from the first cause herein specified, but we shall cany our discussion no further than to consider whether, upon *825 this record, it can be said: (1) That the product delivered to the plaintiff, contained the germs of hemorrhagic septicemia and necrotic enteritis; (2) that the defendant was guilty of any negligence in its method of producing the product delivered to the defendant.

Incidentally, also, the consideration of the first of these questions involves the question whether the use of the serum was the proximate cause of these diseases in the hogs upon which it was used. Appellant has assigned a large number of errors. We shall not consider them seriatim. All the material questions in this ease resolve themselves into one comprehensive one; and that is whether the methods and standard laid down by government regulations make up the standard which measures the duty of the defendant, and whether a careful compliance with all such regulations by defendant still leaves it subject to a charge of negligence on the ground that it failed to observe some additional precaution, not required by government regulation. The specification is that the defendant had no “laboratory facilities” for testing its product. The conceded evidence is that it had no bacteriological laboratory. It is not claimed to have been lacking in any other “laboratory facilities.” Its plant was a laboratory, and all its facilities were under the supervision of, and had the approval of, government agencies. There was no lack of test requirements in the government regulations. The required test, however, was not bacteriological. The method of testing will be set forth later. Of the many expert witnesses testifying at the trial, none testified that a bacteriological test was essential, saAre Dr. Cecil. He predicated his opinion solely upon the fact that a test could be so made. It would require some weeks to make each test. Such test would not be accepted as sufficient by government regulations. It appears, also, that there are 57 plants engaged in this production, all under the supervision of the government. The production of serum and virus is the exclusive product of 52 of these plants. None of them use the bacteriological test. The five other plants are engaged in producing not only serum and virus, but other products, which require bacteriological examination. It is shown that these plants have bacteriological laboratories. Whatever support, therefore, the fifth specification has, it is in these facts now stated.

It is to be borne in mind that the Federal government lias *826

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Denman v. ARMOUR PHARMACEUTICAL COMPANY
322 F. Supp. 1370 (N.D. Mississippi, 1970)
Brown v. Globe Laboratories, Inc.
84 N.W.2d 151 (Nebraska Supreme Court, 1957)
Parker v. State
201 Misc. 416 (New York State Court of Claims, 1951)
Tremaine, Exrx. v. H. K. Mulford Co.
176 A. 212 (Supreme Court of Pennsylvania, 1934)

Cite This Page — Counsel Stack

Bluebook (online)
211 N.W. 419, 202 Iowa 822, Counsel Stack Legal Research, https://law.counselstack.com/opinion/howard-v-united-serum-co-iowa-1926.